Article by Olga Chernoloz, Omnica Biotech via The GrowthOp A new study out of Australia investigating the entourage effect theory concludes that terpenes most commonly found in the cannabis plant did not change the effect that THC produces at cannabinoid CB1 and CB2 receptors. What do the study findings say about the entourage effect, and is it time to shift long-held perceptions? … ...

Article by Harrison Mooney, Vancouver Sun As expected, Canada is going to pot. Marijuana use has risen in the country since legalization, according to a new study from Western Canadian research company Insights West, which shows that nearly a quarter of adult Canadians consumed cannabis in the last few months of 2018. In an online study conducted from Dec. 13 ...

Article by  Tim Kelly, Thornhill Liberal via York Region A mother is thankful to a Thornhill doctor — and the wonders of CBD oil for what she says has been the elimination of her young daughter’s severe epileptic seizures. Carrie Calhoun’s daughter, Quinn, had started developing the seizures just after her second birthday. They were so frequent and so debilitating ...

Article by Shanthi Rexaline , Benzinga Whenever pot is discussed, two acronyms — tetrahydrocannabinol, or THC, and cannabidiol, or CBD — are usually mentioned in the same breath. The following is a look at how the substances differ. The Science Cannabis sativa, an annual herbaceous flowering plant, has numerous uses thanks to the multiple natural compounds present. Cannabinoid, or phytocannabinoid, is ...

Article by Lorraine Lorenzo, International Business Times Ever since Canada fully legalized the use of both medical and recreational marijuana and the 2018 U.S. Farm Bill federally legalizing hemp, the future of weed has reached new highs. First, marijuana’s growth projection has increased exponentially. According to Wall Street’s cannabis analyst, Vivien Azer, the U.S. sales of marijuana will rise to as much ...

Article by Benefits Canada  Two-thirds (65 per cent) of Canadians would take a drug containing cannabis if it were prescribed by a doctor, approved by Health Canada and covered by insurance, according to a new Ipsos poll. Among the 65 per cent, 36 per cent said they’re very willing and 29 per cent said they’re somewhat willing to do so. Men (69 per ...

Article by Allan Maki, Globe and Mail The National Hockey League Alumni Association is offering “hope and help” to its ailing members through a clinical research initiative that includes diagnosis, treatment and the use of cannabinoids [CBD] for pain management. NHLAA executive director Glenn Healy will unveil the program Saturday in Toronto and has called it “the most ambitious project ...

Article by Angela Stelmakowich, The GrowthOp A mix of trust and practicality could convince surveyed Canadians to try pharmaceutical drugs containing cannabis, with 65 percent of respondents to a recent Ipsos poll saying they would be willing if prescribed by a doctor, approved by Health Canada and covered by public or private insurance. More specifically, 36 percent of respondents say ...

Article by Elie Dolgin, Nature The yeast that people have used for millennia to brew alcoholic drinks has now been engineered to produce cannabinoids — chemicals with medicinal and sometimes mind-altering properties found in cannabis. The feat1, described on 27 February in Nature, turns a sugar in brewer’s yeast (Saccharomyces cerevisiae) called galactose into tetrahydrocannabinol (THC), the main psychoactive compound in cannabis ...

Article by Solomon Israel, Leaf News Provinces with a higher proportion of licensed bricks-and-mortar cannabis stores are selling considerably more cannabis per capita than provinces with less storefront access to legal marijuana, says a Brock University professor who crunched Statistics Canada’s latest retail trade data for cannabis. The December data show that $55.2 million worth of legal cannabis was sold in Canada, a ...